ArticleGene therapy2018

Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65.

A Georgiadis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.